Formoterol in Diabetes

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 120 participants.

Also called NCT07022418

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07022418
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07022418. Randomized; no masking; primary purpose treatment. Start 2025-12-01 (actual); primary completion 2026-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Formoterol in Diabetes
Condition
Diabetic Nephropathies
Condition
Diabetic Kidney Disease
Intervention (Drug)
Formoterol furmarate (20 μg)
Lead sponsor
Medical University of South Carolina (class: other)
Collaborator
Dialysis Clinic, Inc. (class: industry)

Record details

Record id
cardio:ct-nct07022418
Content hash
d1adcab8b19b1563809f84167e392a3bd39cefbc5aea8957df9d7de43f6e5140